funder-graph

FundersCAPediatric Cancer Research Foundation › 2023

Grants paid by Pediatric Cancer Research Foundation, tax year 2023

EIN 95-3772528 · Irvine, CA · Form 990, Schedule I

In tax year 2023, Pediatric Cancer Research Foundation (EIN 95-3772528) reported 15 grants paid totaling $1,645,724. Dataset version 2026.09.0, built 2026-09-03.

2018202020212022202320242025

Every grant, 2023

Grants reported by Pediatric Cancer Research Foundation for tax year 2023
Tax yearRecipientMatchAmountTypePurposeSource filing
2023New York Medical College Valhalla, NYA$550,000paidPEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE202402729349300305
2023Memorial Sloan Kettering New York, NYA$150,000paidTOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS202402729349300305
2023Ucsf San Francisco, CAA$115,000paidTACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA202402729349300305
2023Stanford University Palo Alto, CAA$115,000paidTARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML202402729349300305
2023Dana Farber Boston, MAA$105,000paidPROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA202402729349300305
2023Md Anderson Houston, TXA$91,717paidCOMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY202402729349300305
2023Case Western Clevenland, OHA$75,000paidUSE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS202402729349300305
2023Baylor College of Medicine Houston, TXA$75,000paidOFF-THE-SHELF COMBINATION CANCER IMMUNOTHERAPY WITH ONCOLYTIC ADENO-IMMUNOTHERAPY AND CAR NK CELL THERAPY FOR PEDIATRIC SARCOMA202402729349300305
2023University of Alabama Birmingham Birmingham, ALA$74,007paidINTRANASAL DELIVERY OF TARGETING NANOLIPOSOMAL THERAPEUTICS FOR PEDIATRIC GLIOMA202402729349300305
2023UCLA Foundation Los Angeles, CAA$70,000paidRESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE OF AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER.202402729349300305
2023Mayo Clinic Rochester, MNA$50,000paidTARGETING TRANSCRIPTIONAL DEPENDENCIES IN ATYPICAL TERATOID RHABDOID TUMOR202402729349300305
2023University of Florida Gainesville, FLA$50,000paidINVESTIGATING THE IMMUNE RESPONSE TO RNA-LIPID NANOPARTICLE VACCINES IN A CLINICAL TRIAL FOR CANINES WITH OSTEOSARCOMA202402729349300305
2023New York University School of Medicine New York, NYA$50,000paidMODULATING THE IMMUNE MICROENVIRONMENT IN PEDIATRIC ACUTE MYELOID LEUKEMIA202402729349300305
2023Hope for Henry Washington, DCA$50,000paidREWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE202402729349300305
2023City of Hope Duarte, CAU$25,000paidREPORTER T CELL LINE GENERATION202402729349300305

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.